Business Description
Grape King Bio Ltd
ISIN : TW0001707008
Description
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 26.59 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 874.08 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.7 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | 0.7 | |||||
3-Year EPS without NRI Growth Rate | 1.6 | |||||
3-Year FCF Growth Rate | 5.6 | |||||
3-Year Book Growth Rate | 11.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.87 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.58 | |||||
9-Day RSI | 34.2 | |||||
14-Day RSI | 36.18 | |||||
6-1 Month Momentum % | 4.22 | |||||
12-1 Month Momentum % | -5.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.61 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 117.96 | |||||
Days Sales Outstanding | 10.91 | |||||
Days Payable | 51.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.54 | |||||
Dividend Payout Ratio | 0.72 | |||||
3-Year Dividend Growth Rate | 2 | |||||
Forward Dividend Yield % | 4.54 | |||||
5-Year Yield-on-Cost % | 4.5 | |||||
3-Year Average Share Buyback Ratio | -2.8 | |||||
Shareholder Yield % | 4.38 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.08 | |||||
Operating Margin % | 22.83 | |||||
Net Margin % | 13.29 | |||||
FCF Margin % | 18.16 | |||||
ROE % | 14.67 | |||||
ROA % | 9.46 | |||||
ROIC % | 20.67 | |||||
ROC (Joel Greenblatt) % | 34.52 | |||||
ROCE % | 22.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.92 | |||||
PE Ratio without NRI | 15.93 | |||||
Shiller PE Ratio | 13.97 | |||||
Price-to-Owner-Earnings | 17.78 | |||||
PEG Ratio | 17.7 | |||||
PS Ratio | 2.11 | |||||
PB Ratio | 2.21 | |||||
Price-to-Tangible-Book | 2.24 | |||||
Price-to-Free-Cash-Flow | 11.69 | |||||
Price-to-Operating-Cash-Flow | 8.96 | |||||
EV-to-EBIT | 6.79 | |||||
EV-to-Forward-EBIT | 7.45 | |||||
EV-to-EBITDA | 5.77 | |||||
EV-to-Forward-EBITDA | 6.68 | |||||
EV-to-Revenue | 1.66 | |||||
EV-to-Forward-Revenue | 1.89 | |||||
EV-to-FCF | 9.2 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Graham-Number | 1.26 | |||||
Price-to-Net-Current-Asset-Value | 30.72 | |||||
Earnings Yield (Greenblatt) % | 14.72 | |||||
FCF Yield % | 8.62 | |||||
Forward Rate of Return (Yacktman) % | 9.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Grape King Bio Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 10,763.28 | ||
EPS (TTM) (NT$) | 9.61 | ||
Beta | 0.48 | ||
Volatility % | 20.26 | ||
14-Day RSI | 36.18 | ||
14-Day ATR (NT$) | 1.803913 | ||
20-Day SMA (NT$) | 156.725 | ||
12-1 Month Momentum % | -5.31 | ||
52-Week Range (NT$) | 147.5 - 189 | ||
Shares Outstanding (Mil) | 148.14 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Grape King Bio Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Grape King Bio Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Grape King Bio Ltd Frequently Asked Questions
What is Grape King Bio Ltd(TPE:1707)'s stock price today?
The current price of TPE:1707 is NT$153.00. The 52 week high of TPE:1707 is NT$189.00 and 52 week low is NT$147.50.
When is next earnings date of Grape King Bio Ltd(TPE:1707)?
The next earnings date of Grape King Bio Ltd(TPE:1707) is .
Does Grape King Bio Ltd(TPE:1707) pay dividends? If so, how much?
The Dividend Yield %  of Grape King Bio Ltd(TPE:1707) is 4.54% (As of Today), Highest Dividend Payout Ratio of Grape King Bio Ltd(TPE:1707) was 0.73. The lowest was 0.59. And the median was 0.69. The  Forward Dividend Yield % of Grape King Bio Ltd(TPE:1707) is 4.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |